Cargando…
Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO
Sinonasal cancers (SNCs) are rare and heterogeneous in histology and biological behavior. The prognosis is generally unfavorable, especially in inoperable cases. In recent years, for some histologies, such as undifferentiated sinonasal carcinoma (SNUC), multimodal treatment with a combination of ind...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095070/ https://www.ncbi.nlm.nih.gov/pubmed/37048714 http://dx.doi.org/10.3390/jcm12072624 |
_version_ | 1785023993318735872 |
---|---|
author | Vischioni, Barbara Ingargiola, Rossana Bonora, Maria Ronchi, Sara Camarda, Anna Maria Russo, Stefania Rossi, Eleonora Magro, Giuseppe Mirandola, Alfredo Orlandi, Ester |
author_facet | Vischioni, Barbara Ingargiola, Rossana Bonora, Maria Ronchi, Sara Camarda, Anna Maria Russo, Stefania Rossi, Eleonora Magro, Giuseppe Mirandola, Alfredo Orlandi, Ester |
author_sort | Vischioni, Barbara |
collection | PubMed |
description | Sinonasal cancers (SNCs) are rare and heterogeneous in histology and biological behavior. The prognosis is generally unfavorable, especially in inoperable cases. In recent years, for some histologies, such as undifferentiated sinonasal carcinoma (SNUC), multimodal treatment with a combination of induction chemotherapy, surgery, and chemo/radiotherapy (RT) has improved the prognosis. Nevertheless, still about half of the patients treated incur a recurrence, in most of the cases at the local site. Surgery with and without RT is usually the treatment choice in cases of recurrence after previous RT in combination with systemic therapy or RT in a histology-driven fashion. In the case of inoperable disease or contraindications to surgery, RT is still a valid treatment option. In this context, hadron therapy with protons (PT) or carbon ions (CIRT) is often preferred due to the physical and biological characteristics of charged particles, allowing the administration of high doses to the tumor target while sparing the surrounding healthy tissues and potentially limiting the side effects due to the high cumulative dose. In the absence of a standard of care for the recurrent setting, we aimed to investigate the role of re-RT with PT or CIRT. We retrospectively analysed 15 patients with recurrent, previously irradiated, SNCs treated at our institution between 2013 and 2020. Local control (LC) and overall survival (OS) were estimated by the Kaplan–Meier method. Acute and late toxicities were scored according to the National Cancer Institute’s Common Terminology Criteria for Adverse Events CTCAE version 5.0. A total of 13 patients received CIRT and 2 patients received PT. The median re-RT dose was 54 GyRBE (range 45–64 GyRBE) delivered in 3 or 4 GyRBE/fr (fraction) for the CIRT, and 2 Gy RBE/fr for the PT schedule. LC was 44% at the 1-year follow-up and 35.2% at the 3-year follow-up. OS at 1 and 3 years were 92.9% and 38.2%, respectively. Fourteen patients developed G1–G2 acute toxicity (dermatitis and mucositis), and no patients developed G3–G5. Regarding late toxicity, 10 patients encountered at maximum G1–2 events, and 4 did not experience any toxicity. Only for one patient G3 late toxicity was reported (dysphagia requiring a percutaneous endoscopic gastrostomy). |
format | Online Article Text |
id | pubmed-10095070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100950702023-04-13 Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO Vischioni, Barbara Ingargiola, Rossana Bonora, Maria Ronchi, Sara Camarda, Anna Maria Russo, Stefania Rossi, Eleonora Magro, Giuseppe Mirandola, Alfredo Orlandi, Ester J Clin Med Article Sinonasal cancers (SNCs) are rare and heterogeneous in histology and biological behavior. The prognosis is generally unfavorable, especially in inoperable cases. In recent years, for some histologies, such as undifferentiated sinonasal carcinoma (SNUC), multimodal treatment with a combination of induction chemotherapy, surgery, and chemo/radiotherapy (RT) has improved the prognosis. Nevertheless, still about half of the patients treated incur a recurrence, in most of the cases at the local site. Surgery with and without RT is usually the treatment choice in cases of recurrence after previous RT in combination with systemic therapy or RT in a histology-driven fashion. In the case of inoperable disease or contraindications to surgery, RT is still a valid treatment option. In this context, hadron therapy with protons (PT) or carbon ions (CIRT) is often preferred due to the physical and biological characteristics of charged particles, allowing the administration of high doses to the tumor target while sparing the surrounding healthy tissues and potentially limiting the side effects due to the high cumulative dose. In the absence of a standard of care for the recurrent setting, we aimed to investigate the role of re-RT with PT or CIRT. We retrospectively analysed 15 patients with recurrent, previously irradiated, SNCs treated at our institution between 2013 and 2020. Local control (LC) and overall survival (OS) were estimated by the Kaplan–Meier method. Acute and late toxicities were scored according to the National Cancer Institute’s Common Terminology Criteria for Adverse Events CTCAE version 5.0. A total of 13 patients received CIRT and 2 patients received PT. The median re-RT dose was 54 GyRBE (range 45–64 GyRBE) delivered in 3 or 4 GyRBE/fr (fraction) for the CIRT, and 2 Gy RBE/fr for the PT schedule. LC was 44% at the 1-year follow-up and 35.2% at the 3-year follow-up. OS at 1 and 3 years were 92.9% and 38.2%, respectively. Fourteen patients developed G1–G2 acute toxicity (dermatitis and mucositis), and no patients developed G3–G5. Regarding late toxicity, 10 patients encountered at maximum G1–2 events, and 4 did not experience any toxicity. Only for one patient G3 late toxicity was reported (dysphagia requiring a percutaneous endoscopic gastrostomy). MDPI 2023-03-31 /pmc/articles/PMC10095070/ /pubmed/37048714 http://dx.doi.org/10.3390/jcm12072624 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vischioni, Barbara Ingargiola, Rossana Bonora, Maria Ronchi, Sara Camarda, Anna Maria Russo, Stefania Rossi, Eleonora Magro, Giuseppe Mirandola, Alfredo Orlandi, Ester Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO |
title | Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO |
title_full | Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO |
title_fullStr | Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO |
title_full_unstemmed | Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO |
title_short | Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO |
title_sort | particle reirradiation of malignant epithelial and neuroectodermal sinonasal tumors: a case series from cnao |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095070/ https://www.ncbi.nlm.nih.gov/pubmed/37048714 http://dx.doi.org/10.3390/jcm12072624 |
work_keys_str_mv | AT vischionibarbara particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT ingargiolarossana particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT bonoramaria particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT ronchisara particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT camardaannamaria particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT russostefania particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT rossieleonora particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT magrogiuseppe particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT mirandolaalfredo particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao AT orlandiester particlereirradiationofmalignantepithelialandneuroectodermalsinonasaltumorsacaseseriesfromcnao |